Pipeline

At Chiesi, our portfolio and pipeline are focused on developing and bringing to market innovative pharmaceutical solutions that improve quality of people’s life, with a strong focus on our core therapeutic areas: respiratory diseases, rare and ultra-rare diseases, neonatology, special and primary care.

This strategic choice allows us to continue expanding and strengthening our pipeline with studies that promise significant advancements for the future of our company, while also offering new opportunities for patients with unmet medical needs who currently lack therapeutic options for their conditions.